Mateusz Adam Krzyscik (Mateusz A Krzyscik, Mateusz Adam Krzyścik)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Topics

Extracellular Matrix

Top Venues

International journal of molecular sciences

Molecular pharmaceutics

Biomacromolecules

Bioconjugate chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Daria Nawrocka, Mateusz Adam Krzyscik, Katarzyna Dominika Sluzalska, Jacek Otlewski
Dual-Warhead Conjugate Based on Fibroblast Growth Factor 2 Dimer Loaded with α-Amanitin and Monomethyl Auristatin E Exhibits Superior Cytotoxicity towards Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1. International journal of molecular sciences 24 (12) (2023)
Daria Nawrocka, Mateusz Adam Krzyscik, Katarzyna Dominika Sluzalska, Jacek Otlewski
Dual-Warhead Conjugate Based on Fibroblast Growth Factor 2 Dimer Loaded with α-Amanitin and Monomethyl Auristatin E Exhibits Superior Cytotoxicity towards Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1. International journal of molecular sciences 24 (12) (2023)
Daria Nawrocka, Mateusz Adam Krzyscik, Katarzyna Dominika Sluzalska, Jacek Otlewski
Dual-Warhead Conjugate Based on Fibroblast Growth Factor 2 Dimer Loaded with α-Amanitin and Monomethyl Auristatin E Exhibits Superior Cytotoxicity towards Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1. International journal of molecular sciences 24 (12) (2023)
Marta Poźniak, Dominika Żukowska, Aleksandra Gędaj, Mateusz Adam Krzyscik, Natalia Porębska, Malgorzata Zakrzewska, Jacek Otlewski, Łukasz Opaliński
The Significance of Cell Surface N-Glycosylation for Internalization and Potency of Cytotoxic Conjugates Targeting Receptor Tyrosine Kinases. International journal of molecular sciences 23 (15) (2022)
Karolina Jendryczko, Jakub Rzeszotko, Mateusz Adam Krzyscik, Anna Kocyła, Jakub Szymczyk, Jacek Otlewski, Anna Szlachcic
Drug Conjugation via Maleimide-Thiol Chemistry Does Not Affect Targeting Properties of Cysteine-Containing Anti-FGFR1 Peptibodies. Molecular pharmaceutics 19 (5) (2022)
Natalia Porębska, Agata Knapik, Marta Poźniak, Mateusz Adam Krzyscik, Małgorzata Zakrzewska, Jacek Otlewski, Lukasz Opalinski
Intrinsically Fluorescent Oligomeric Cytotoxic Conjugates Toxic for FGFR1-Overproducing Cancers. Biomacromolecules (2021)
Mateusz Adam Krzyscik, Malgorzata Zakrzewska, Vigdis Sørensen, Geir Frode Øy, Skjalg Brunheim, Ellen M Haugsten, Gunhild M Mælandsmo, Antoni Wiedlocha, Jacek Otlewski
Fibroblast Growth Factor 2 Conjugated with Monomethyl Auristatin E Inhibits Tumor Growth in a Mouse Model. Biomacromolecules 22 (10) (2021)
Mateusz Adam Krzyscik, Malgorzata Zakrzewska, Jacek Otlewski
Site-Specific, Stoichiometric-Controlled, PEGylated Conjugates of Fibroblast Growth Factor 2 (FGF2) with Hydrophilic Auristatin Y for Highly Selective Killing of Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1 (FGFR1). Molecular pharmaceutics 17 (7) (2020)
Daria Nawrocka, Mateusz Adam Krzyscik, Łukasz Opaliński, Malgorzata Zakrzewska, Jacek Otlewski
Stable Fibroblast Growth Factor 2 Dimers with High Pro-Survival and Mitogenic Potential. International journal of molecular sciences 21 (11) (2020)
Mateusz Adam Krzyscik, Łukasz Opaliński, Jacek Otlewski
Novel Method for Preparation of Site-Specific, Stoichiometric-Controlled Dual Warhead Conjugate of FGF2 via Dimerization Employing Sortase A-Mediated Ligation. Molecular pharmaceutics 16 (8) (2019)
Michal Lobocki, Malgorzata Zakrzewska, Anna Szlachcic, Mateusz Adam Krzyscik, Aleksandra Sokolowska-Wedzina, Jacek Otlewski
High-Yield Site-Specific Conjugation of Fibroblast Growth Factor 1 with Monomethylauristatin E via Cysteine Flanked by Basic Residues. Bioconjugate chemistry 28 (7) (2017)